bioMérieux S.A.
BMXXY | OTC
$10.19
+$0.21 (+2.10%)
At close: Oct 15, 2026, 2:40 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.96B | 2.03B | 2.04B | 2.08B | 1.9B | 1.9B | 1.77B | 1.93B | 1.66B | 1.8B | 1.57B |
Cost of Revenue | 880.6M | 1.03B | 876.9M | 966.2M | 856.8M | 933.5M | 854.5M | 912.1M | 744.9M | 761.8M | 667.5M |
Gross Profit | 1.08B | 992.8M | 1.17B | 1.11B | 1.05B | 971.1M | 915.6M | 1.02B | 913.1M | 1.04B | 906.7M |
Operating Income | 299.2M | 179.1M | 209.2M | 299.7M | 268.1M | 219.1M | 187M | 265.3M | 265.5M | 394M | 345.6M |
Interest Income | 1M | 6.6M | 7.7M | 12.1M | 2.3M | 500K | 600K | 600K | 600K | 800K | 900K |
Pretax Income | 294.6M | 312.4M | 213.2M | 280.6M | 269.3M | 218.4M | 194.3M | 272.2M | 278M | 402.1M | 346.2M |
Net Income | 226.1M | 236.3M | 161M | 216.9M | 215.3M | 196M | 161.6M | 224.3M | 228M | 324M | 277.1M |
Selling & General & Admin | 544.3M | 542.4M | 568.8M | 561.4M | 536.2M | 518.4M | 502.1M | 514.4M | 440.3M | 438.7M | 379.6M |
Research & Development | 257.4M | 271.3M | 414M | 250.7M | 240.8M | 233.6M | 226.5M | 239.3M | 207.3M | 207.5M | 181.5M |
Other Expenses | -16.9M | n/a | -25.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 784.8M | 813.7M | 957.7M | 812.1M | 777M | 752M | 728.6M | 753.7M | 647.6M | 646.2M | 561.1M |
Interest Expense | n/a | 8.3M | 7.5M | 12.8M | 3.2M | 2.2M | 2.2M | n/a | 4.9M | 3.9M | 5.2M |
Selling & Marketing Expenses | n/a | 383.4M | 407.8M | 394.7M | 389.1M | 369.5M | 356M | 383.3M | 318.2M | 307.2M | 266.3M |
Cost & Expenses | 1.67B | 1.85B | 1.83B | -1.78B | 1.63B | 1.69B | 1.58B | 1.67B | 1.39B | 1.41B | 1.23B |
Income Tax Expense | 68.8M | 76.2M | 52.6M | 70.4M | 54.4M | 34.3M | 55.6M | 57.9M | 51.8M | 80.1M | 69.3M |
Shares Outstanding (Basic) | 117.76M | 117.77M | 118.91M | 117.92M | 117.93M | 118.15M | 117.96M | 117.95M | 118.37M | 118.27M | 118.2M |
Shares Outstanding (Diluted) | 118.38M | 118.98M | 118.91M | 118.94M | 118.59M | 118.96M | 118.61M | 118.51M | 118.37M | 119.07M | 118.69M |
EPS (Basic) | 1.92 | 2.01 | 1.35 | 1.84 | 1.83 | 1.66 | 1.37 | 1.90 | 1.93 | 2.74 | 2.34 |
EPS (Diluted) | 1.91 | 1.99 | 1.35 | 1.82 | 1.82 | 1.65 | 1.36 | 1.89 | 1.93 | 2.72 | 2.33 |
EBITDA | 441.2M | 475.9M | 475.7M | 482.7M | 408.8M | 423M | 383.1M | 433.5M | 408.2M | 548.4M | 456.9M |
EBIT | 299.2M | 179.1M | 354.2M | 293.4M | 272.6M | 220.6M | 196.5M | 272.2M | 282.9M | 406M | 351.4M |
Depreciation & Amortization | 142M | 296.8M | 121.5M | 189.3M | 136.2M | 202.4M | 186.6M | 161.3M | 125.3M | 142.4M | 105.5M |
Add to Watchlist
Select watchlists to add or remove BMXXY